Skip to main content
Premium Trial:

Request an Annual Quote

Origene Collaborating with PROOF Centre on Protein Diagnostics for Heart and Kidney Transplants

Premium

Canada's Centre of Excellence for the Prevention of Organ Failure – also called the PROOF Centre – has partnered with Origene Technologies on blood-based protein assays for monitoring heart and kidney transplantation.

The agreement covers a multi-year project that aims to provide monitoring and predictive blood tests for heart and kidney transplant patients. Origene will use its experience in monoclonal antibody production and Luminex multiplex assay development to build and implement diagnostic assays for transplant care, the company said in a statement.

It added that this was "the first announced clinical development project" using Origene's UltraMAB antibodies – a recently released line of antibodies that the company said are "validated for specificity and low cross-reactivity."

According to a recent study by the PROOF Centre, implementation of blood-based protein tests for organ rejection could save British Columbia up to C$700,000 (US$700,000) over five years.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.